- ￥2260
- LSM Bio
- 进口
- PAab09782
- 2025年07月14日
- ELISA, IHC
- E. coli - derived recombinant protein
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
CD6 molecule
- 亚型：
IgG
- 形态：
liquid
- 保存条件：
负20摄氏度
- 克隆性：
polyclonal
- 标记物：
Non-conjugated
- 适应物种：
Human
- 保质期：
6个月
- 抗原来源：
Rabbit
- 目录编号：
Q9BZJ3
- 级别：
纯化级别
- 库存：
50
- 供应商：
LSM bio
- 宿主：
E. coli - derived recombinant protein
- 应用范围：
ELISA, IHC
- 浓度：
≥95% as determined by SDS-PAGE
- 靶点：
CD6 molecule
- 抗体英文名：
CD6 antibody
- 抗体名：
CD6 antibody
- 规格：
100μl
CD6 antibody
Product Name CD6 antibody
Catalog No PAab09782
Packing 100ul
Form liquid
Alternative Name CD6, CD6 molecule, FLJ44171, T12, TP120
Purification Immunogen affinity purified
Purity 95% as determined by SDS-PAGE
Host Rabbit
Isotype IgG
Storage PBS with 0.02% sodium azide and 50% glycerol pH 7.3 , -20Centigrade for 24 months (Avoid repeated freeze / thaw cycles.)
Background/ FUNCTION
Immunogen CD6 molecule
Specificity Human
Tested Application ELISA, IHC
Recommended dilution IHC: 1:20-1:200
IHC use Immunohistochemistry of paraffin-embedded human tonsillitis tissue slide using PAab09782(CD6 Antibody) at dilution of 1:200 . heat mediated antigen retrieved with Tris-EDTA buffer(pH9).
WB use
Protein Information
Gene ID
Uniprot ID P30203
Calculated MW 72 kDa
Research Area Immunology, Signal Transduction
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验CD6 分子 常用单克隆抗体或代号：T12，T411 主要表达细胞：TsuL，Bsub，Thy[T] 分子质量(kDa)和结构：gp100(清除剂受体) 功 能：配体CDl66，T细胞活化，胸腺细胞与基质细胞相互作用 Adhesion molecule mediating the binding of developing thymocytes with thymic epithelial cells May be involved
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
The importance of antibody molecules was first recognized in the 1890s, when it was shown that immunity to tetanus and diphtheria was caused by antibodies against the bacterial exotoxins (1 ). Around the same time, it was shown that antisera
技术资料暂无技术资料 索取技术资料
